BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25119048)

  • 1. X-ray structure of the mouse serotonin 5-HT3 receptor.
    Hassaine G; Deluz C; Grasso L; Wyss R; Tol MB; Hovius R; Graff A; Stahlberg H; Tomizaki T; Desmyter A; Moreau C; Li XD; Poitevin F; Vogel H; Nury H
    Nature; 2014 Aug; 512(7514):276-81. PubMed ID: 25119048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Changes in the 5-HT
    Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional crystallization of the mouse serotonin 5-HT
    Rheinberger J; Hassaine G; Chami M; Stahlberg H; Vogel H; Li X
    Micron; 2017 Jan; 92():19-24. PubMed ID: 27825023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of ligand recognition in 5-HT3 receptors.
    Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
    EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor.
    Peters JA; Hales TG; Lambert JJ
    Trends Pharmacol Sci; 2005 Nov; 26(11):587-94. PubMed ID: 16194573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT3 receptor--the relationship between structure and function.
    Barnes NM; Hales TG; Lummis SC; Peters JA
    Neuropharmacology; 2009 Jan; 56(1):273-84. PubMed ID: 18761359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Gating Mechanism of the Serotonin 5-HT3 Receptor.
    Yuan S; Filipek S; Vogel H
    Structure; 2016 May; 24(5):816-825. PubMed ID: 27112600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.
    Baptista-Hon DT; Deeb TZ; Lambert JJ; Peters JA; Hales TG
    J Biol Chem; 2013 Jul; 288(30):21558-68. PubMed ID: 23740249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structure of the Mouse Serotonin 5-HT3 Receptor in Lipid Vesicles.
    Kudryashev M; Castaño-Díez D; Deluz C; Hassaine G; Grasso L; Graf-Meyer A; Vogel H; Stahlberg H
    Structure; 2016 Jan; 24(1):165-170. PubMed ID: 26724993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the
    Brams M; Govaerts C; Kambara K; Price KL; Spurny R; Gharpure A; Pardon E; Evans GL; Bertrand D; Lummis SC; Hibbs RE; Steyaert J; Ulens C
    Elife; 2020 Jan; 9():. PubMed ID: 31990273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT3 receptor as a therapeutic target.
    Thompson AJ; Lummis SC
    Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel.
    Lummis SC; Beene DL; Lee LW; Lester HA; Broadhurst RW; Dougherty DA
    Nature; 2005 Nov; 438(7065):248-52. PubMed ID: 16281040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intracellular domain flexibility upon properties of activated human 5-HT3 receptors.
    Kozuska JL; Paulsen IM; Belfield WJ; Martin IL; Cole DJ; Holt A; Dunn SM
    Br J Pharmacol; 2014 Apr; 171(7):1617-28. PubMed ID: 24283776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neural γ
    Ayan M; Essiz S
    J Mol Model; 2018 Jul; 24(8):206. PubMed ID: 30008086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP.
    Price KL; Lillestol RK; Ulens C; Lummis SC
    ACS Chem Neurosci; 2015 Jul; 6(7):1151-7. PubMed ID: 25648658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
    Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
    Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review).
    Reeves DC; Lummis SC
    Mol Membr Biol; 2002; 19(1):11-26. PubMed ID: 11989819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT3 receptors.
    Thompson AJ; Lummis SC
    Curr Pharm Des; 2006; 12(28):3615-30. PubMed ID: 17073663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.